{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:07:55Z","timestamp":1788286075092,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jhep.2018.02.029","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T19:12:09Z","timestamp":1521400329000},"page":"89-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"69","author":[{"given":"Liang-Qing","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Zi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Hao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Bin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Wu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibin","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2018.02.029_b0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The global burden of cancer 2013","volume":"1","author":"Fitzmaurice","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhep.2018.02.029_b0010","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine vs. gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.02.029_b0015","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.02.029_b0020","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ng.2273","article-title":"Exome sequencing of liver fluke-associated cholangiocarcinoma","volume":"44","author":"Ong","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2018.02.029_b0025","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Jiao","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2018.02.029_b0030","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1038\/ncomms6696","article-title":"Mutational landscape of intrahepatic cholangiocarcinoma","volume":"341","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2018.02.029_b0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-13-0642","article-title":"Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy","volume":"4","author":"Shi","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2018.02.029_b0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature14347","article-title":"The evolutionary history of lethal metastatic prostate cancer","volume":"520","author":"Gundem","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2018.02.029_b0045","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non-small-cell lung cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.02.029_b0050","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.18632\/oncotarget.6558","article-title":"Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity","volume":"7","author":"Shi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhep.2018.02.029_b0055","first-page":"87","article-title":"Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing","volume":"65","author":"Duan","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.jhep.2018.02.029_b0060","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.02.029_b0065","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.1254721","article-title":"Patient-derived models of acquired resistance can identify effective drug combinations for cancer","volume":"346","author":"Crystal","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jhep.2018.02.029_b0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhep.2016.04.009","article-title":"Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer","volume":"65","author":"Bissig-Choisat","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.02.029_b0075","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1053\/j.gastro.2016.09.008","article-title":"Cell culture system for analysis of genetic heterogeneity withinhepatocellular carcinomas and response to pharmacologic agents","volume":"152","author":"Gao","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.02.029_b0080","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1038\/ncomms9971","article-title":"Systematic pan-cancer analysis of tumour purity","volume":"6","author":"Aran","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2018.02.029_b0085","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/2159-8290.CD-15-0412","article-title":"Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy","volume":"5","author":"Murugaesu","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2018.02.029_b0090","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1038\/ncomms14565","article-title":"The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma","volume":"8","author":"Zhai","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2018.02.029_b0095","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nmeth.2883","article-title":"PyClone: statistical inference of clonal population structure in cancer","volume":"11","author":"Roth","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.jhep.2018.02.029_b0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa1408","article-title":"Clonal status of actionable driver events and the timing of mutational processes in cancer evolution","volume":"7","author":"McGranahan","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2018.02.029_b0105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.02.029_b0110","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2014-2599","article-title":"Abstract 2599: KDM3A tyrosine phosphorylation by Ack1 promotes tamoxifen-resistance in breast cancer","volume":"74","author":"Mahajan","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2018.02.029_b0115","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2014-5143","article-title":"Abstract 5143: KDM3A promotes cell growth and cisplatin-resistance in ovarian cancer cells","volume":"74","author":"Ramadoss","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2018.02.029_b0120","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2017.08.013","article-title":"Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma","volume":"67","author":"Torrecilla","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.02.029_b0125","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1053\/j.gastro.2014.01.062","article-title":"Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients","volume":"146","author":"Gao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.02.029_b0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ng.2891","article-title":"Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing","volume":"46","author":"Gerlinger","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2018.02.029_b0135","doi-asserted-by":"crossref","first-page":"E2945","DOI":"10.1073\/pnas.1605691113","article-title":"USP6 oncogene promotes Wnt signaling by deubiquitylating Frizzleds","volume":"113","author":"Madan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2018.02.029_b0140","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nm.3886","article-title":"Subclonal diversification of primary breast cancer revealed by multiregion sequencing","volume":"21","author":"Yates","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2018.02.029_b0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2018.02.029_b0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","article-title":"DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution","volume":"17","author":"Rosenthal","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.jhep.2018.02.029_b0155","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.jhep.2018.02.029_b0160","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1093\/nar\/gkw491","article-title":"Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants","volume":"44","author":"Xi","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2018.02.029_b0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/2159-8290.CD-13-0285","article-title":"Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution","volume":"4","author":"Dewhurst","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2018.02.029_b0170","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/0008-5472.CAN-10-3604","article-title":"Chromosomal instability confers intrinsic multidrug resistance","volume":"71","author":"Lee","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2018.02.029_b0175","doi-asserted-by":"crossref","first-page":"S1254","DOI":"10.1016\/S0016-5085(17)34175-6","article-title":"Long-term survival among mismatch repair deficient cholangiocarcinomas associated with lynch syndrome","volume":"152","author":"Cloyd","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.02.029_b0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jhep.2018.02.029_b0185","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature22334","article-title":"A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma","volume":"545","author":"Tammela","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2018.02.029_b0190","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature22323","article-title":"Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer","volume":"545","author":"Lim","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2018.02.029_b0195","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10825","article-title":"Clonal selection drives genetic divergence of metastatic medulloblastoma","volume":"482","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2018.02.029_b0200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.1239947","article-title":"Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma","volume":"343","author":"Johnson","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jhep.2018.02.029_b0205","doi-asserted-by":"crossref","first-page":"14374","DOI":"10.1038\/ncomms14374","article-title":"Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress","volume":"8","author":"Kim","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2018.02.029_b0210","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/2159-8290.CD-14-0623","article-title":"Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2018.02.029_b0215","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.02.029_b0220","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbrc.2010.11.130","article-title":"Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1\/2","volume":"405","author":"Yoon","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2018.02.029_b0225","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1200\/JCO.2009.27.4860","article-title":"Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) vs. FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study","volume":"28","author":"Douillard","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2018.02.029_b0230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2018.02.029_b0235","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1200\/JCO.2016.70.3934","article-title":"Gefitinib and EGFRGene copy number aberrations in esophageal cancer","volume":"35","author":"Petty","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2018.02.029_b0240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad7842","article-title":"Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer","volume":"8","author":"Enriquez-Navas","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2018.02.029_b0245","first-page":"190140","article-title":"Capitalizing on competition: an evolutionary model of competitive release in metastatic castrate resistant prostate cancer treatment","author":"West","year":"2017","journal-title":"bioRxiv"},{"key":"10.1016\/j.jhep.2018.02.029_b0250","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1158\/2159-8290.CD-17-0343","article-title":"Tumor evolution as a therapeutic target","volume":"7","author":"Amirouchene-Angelozzi","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2018.02.029_b0255","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.02.029_b0260","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1038\/ncomms7087","article-title":"Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma","volume":"6","author":"Sia","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2018.02.029_b0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13059-017-1283-2","article-title":"Searching for cancer vulnerabilities amid genetic chaos","volume":"18","author":"Speicher","year":"2017","journal-title":"Genome Biol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818301673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818301673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T12:57:08Z","timestamp":1603976228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827818301673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0168827818301673"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2018.02.029","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2018.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}